Recent Pharmaxis Ltd (ASX: PXS) News

a woman
⏸️ Investing

Why Pharmaxis is down 45%

Shares of pharmaceutical and biotech company Pharmaxis (ASX: PXS) are down nearly 50% today — and down nearly 87% year…

Read more »

⏸️ Investing

Starpharma still reaching for the sky

Growth continues for this biotech hopeful

Read more »

a woman
⏸️ Investing

Pharmaxis set to gain PBS listing for cystic fibrosis treatment

Pharmaxis has gained verbal approval for Bronchitol to be listed on the PBS

Read more »